Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. SPY
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2019 Financial Results

Galmed Pharma (GLMD) Reports Q1 EPS of $0.17

May 7, 2019 7:23 AM EDT

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of $0.17, versus $0.17 reported last year.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

... More